Apparent antinociceptive and anti-inflammatory effects of GYKI 52466

By Szekely J.I.   Kedves R.   Mate I.   Torok K.   Tarnawa I.  

European Journal of Pharmacology, Vol. 336, Iss. 2, 1997-10 ,pp. : 143-154

Elsevier

Access to resources Recommend Favorite

4-Aminopyridine derivatives with antiamnesic activity #

By Andreani A.   Leoni A.   Locatelli A.   Morigi R.   Rambaldi M.   Pietra C.   Villetti G.  

European Journal of Medicinal Chemistry, Vol. 35, Iss. 1, 2000-01 ,pp. : 77-82

Elsevier

Access to resources Recommend Favorite

GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice

By De Sarro G.   Chimirri A.   De Sarro A.   Gitto R.   Grasso S.   Giusti P.   Chapman A.G.  

European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. : 411-422

Elsevier

Access to resources Recommend Favorite

The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics

By Borowicz K.K.   Gasior M.   Kleinrok Z.   Czuczwar S.J.  

European Journal of Pharmacology, Vol. 281, Iss. 3, 1995-08 ,pp. : 319-326

Elsevier

Access to resources Recommend Favorite

Molsidomine potentiates the protective activity of GYKI 52466, a non-NMDA antagonist, MK-801, a non-competitive NMDA antagonist, and riluzole against electroconvulsions in mice

By Tutka P.   Olszewski K.   Wozniak M.   Kleinrok Z.   Czuczwar S.J.   Wielosz M.  

European Neuropsychopharmacology, Vol. 12, Iss. 4, 2002-08 ,pp. : 321-326

Elsevier

Access to resources Recommend Favorite